日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Personalized multifactorial risk assessment in neoadjuvant-treated breast carcinoma

新辅助治疗乳腺癌的个性化多因素风险评估

Korpinen, K; Autere, T A; Tuominen, J; Löyttyniemi, E; Eigeliene, N; Talvinen, K; Kronqvist, P

Prognostic implications of securin expression and sub-cellular localization in human breast cancer.

人乳腺癌中分离蛋白表达和亚细胞定位的预后意义。

Gurvits N, Repo H, Löyttyniemi E, Nykänen M, Anttinen J, Kuopio T, Talvinen K, Kronqvist P

Cdc20 and securin overexpression predict short-term breast cancer survival

Cdc20 和 securin 过表达可预测乳腺癌患者的短期生存率

Karra, H; Repo, H; Ahonen, I; Löyttyniemi, E; Pitkänen, R; Lintunen, M; Kuopio, T; Söderström, M; Kronqvist, P

Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ

非经典Notch信号通路激活乳腺肿瘤细胞中的IL-6/JAK/STAT信号通路,并受p53和IKKα/IKKβ调控。

Jin, S; Mutvei, A P; Chivukula, I V; Andersson, E R; Ramsköld, D; Sandberg, R; Lee, K L; Kronqvist, P; Mamaeva, V; Ostling, P; Mpindi, J-P; Kallioniemi, O; Screpanti, I; Poellinger, L; Sahlgren, C; Lendahl, U

Altered expression of p120catenin predicts poor outcome in invasive breast cancer.

p120catenin表达改变预示着浸润性乳腺癌预后不良

Talvinen K, Tuikkala J, Nykänen M, Nieminen A, Anttinen J, Nevalainen O S, Hurme S, Kuopio T, Kronqvist P

Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer

增殖标志物Securin可预测浸润性导管癌的良好预后

Talvinen, K; Tuikkala, J; Nevalainen, O; Rantanen, A; Hirsimäki, P; Sundström, J; Kronqvist, P

Morphometric grading of breast cancer: thresholds for tubular differentiation

乳腺癌形态计量分级:管状分化的阈值

Kronqvist, P; Kuopio, T; Collan, Y

Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade

浸润性导管乳腺癌的形态计量分级。I. 核分级的阈值

Kronqvist, P; Kuopio, T; Collan, Y

The reproducibility of nuclear morphometric measurements in invasive breast carcinoma

浸润性乳腺癌中核形态测量结果的可重复性

Kronqvist, P; Kuopio, T; Collan, Y; Horvath, C; Tamm, U